• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A novel real-time RT-PCR assay for influenza C tested in Peruvian children

tetano

Editor, Senior Moderator
J Clin Virol. 2017 Sep 1;96:12-16. doi: 10.1016/j.jcv.2017.08.014. [Epub ahead of print]
[h=1]A novel real-time RT-PCR assay for influenza C tested in Peruvian children.[/h] Howard LM[SUP]1[/SUP], Johnson M[SUP]2[/SUP], Gil AI[SUP]3[/SUP], Pekosz A[SUP]4[/SUP], Griffin MR[SUP]5[/SUP], Edwards KM[SUP]1[/SUP], Lanata CF[SUP]6[/SUP], Grijalva CG[SUP]5[/SUP], Williams JV[SUP]7[/SUP]; RESPIRA-PERU Group.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza C virus (ICV) is associated with acute respiratory illness. Yet ICV remains under recognized, with most previous studies using only culture to identify cases.
[h=4]OBJECTIVES:[/h] To develop a sensitive and specific real-time RT-PCR assay for ICV that allows for rapid and accurate detection in a clinical or research setting.
[h=4]STUDY DESIGN:[/h] Multiple ICV sequences obtained from GenBank were analyzed, including 141 hemagglutinin-esterase (HE), 106 matrix (M), and 97 nucleoprotein (NP) sequences. Primers and probes were designed based on conserved regions. Multiple primer-probe sets were tested against multiple ICV strains.
[h=4]RESULTS:[/h] The ICV M and NP genes offered the most conserved sequence regions. Primers and probes based on newer sequence data offered enhanced detection of ICV, especially for low titer specimens. An NP-targeted assay yielded the best performance and was capable of detecting 10-100 RNA copies per reaction. The NP assay detected multiple clinical isolates of ICV collected in a field epidemiology study conducted in Peru.
[h=4]CONCLUSIONS:[/h] We report a new real-time RT-PCR assay for ICV with high sensitivity and specificity.
Copyright ? 2017 Elsevier B.V. All rights reserved.


[h=4]KEYWORDS:[/h] Diagnostics; Influenza C; Real-time RT-PCR

PMID: 28917132 DOI: 10.1016/j.jcv.2017.08.014
 
Back
Top Bottom